DEXANTA Chewable tablet Ref.[115624] Active ingredients: Aluminium hydroxide Magnesium hydroxide Simethicone

Source: Registered Drug Product Database (NG) Revision Year: 2023 Publisher: Applicant / Holder of Certificate of Product Registration: Glorious Dexa Mandaya Ltd., 2nd Floor NIS Building, Plot B, Block H, Elephant Cement Way, Central Business District (CBD), Ikeja, Lagos, Nigeria Manufactured by: PT Beta Pharmacon, Kawasan Industri Suryacipta, Jl. Surya Madya Kav I-18C, Karawang-Indonesia For: PT Dexa Medica, Jl. Jend. Bambang Utoyo No. 138, Palembang-Indonesia

4.3. Contraindications

Should not be used in patients with severe impaired renal function.

4.4. Special warnings and precautions for use

Should not be used continuously for more than 2 weeks, unless directed by a physician.
Should not be used in children under 6 years, unless directed by a physician.
Should be used with caution for long-term therapy and in patients with low-phosphorus diet since it may reduce the blood phosphorus levels.

4.5. Interaction with other medicinal products and other forms of interaction

DEXANTA may interact with certain drugs. Take DEXANTA at least 1–2 hours before or after other antiulcer drugs such as cimetidine or tetracycline antibiotic.

4.6. Pregnancy and lactation

Not applicable.

4.7. Effects on ability to drive and use machines

Not applicable.

4.8. Undesirable effects

Constipation, diarrhea, nausea, vomiting. These symptoms will disappear when the drug is discontinued.

6.2. Incompatibilities

Not applicable.

< Previous: Usage

Next: Pharmacology >

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.